跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
FEXOTABS fexofenadine hydrochloride 180mg tablet blister pack
Approved
STANDARD
FEXOTABS fexofenadine hydrochloride 180mg tablet blister pack
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
33e07b1e262b7250
Company
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Type
Standard
Approval Details
Approval Id
33e07b1e262b7250
Product Name
FEXOTABS fexofenadine hydrochloride 180mg tablet blister pack
Artg Id
98210
Artg Name
FEXOTABS fexofenadine hydrochloride 180mg tablet blister pack
Sponsor
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Company Detail Path
/organization/sanofi-aventis-healthcare-pty-ltd
Artg Date
2003-11-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
33e07b1e262b7250
Type
Standard
Back to TGA Approvals
FEXOTABS fexofenadine hydrochloride 180mg tablet blister pack - TGA Drug Approval Details
